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Purpose: This study aimed to evaluate the effects of fibronectin and oxysterol immobilized 
on machined-surface dental implants for the enhancement of cell attachment and osteo-
genic differentiation, on peri-implant bone healing in the early healing phase using an ex-
perimental model in dogs.
Methods: Five types of dental implants were installed at a healed alveolar ridge in five 
dogs: a machined-surface implant (MI), apatite-coated MI (AMI), fibronectin-loaded AMI 
(FAMI), oxysterol-loaded AMI (OAMI), and sand-blasted, large-grit, acid-etched surface im-
plant (SLAI). A randomly selected unilateral ridge was observed for 2 weeks, and the con-
tralateral ridge for a 4-week period. Histologic and histometric analyses were performed 
for the bone-to-implant contact proportion (BIC) and bone density around the dental im-
plant surface.
Results: Different bone healing patterns were observed according to the type of implant 
surface 2 weeks after installation; newly formed bone continuously lined the entire surfac-
es in specimens of the FAMI and SLAI groups, whereas bony trabecula from adjacent bone 
tissue appeared with minimal new bone lining onto the surface in the MI, AMI, and OAMI 
groups. Histometric results revealed a significant reduction in the BIC in MI, AMI, and OAMI 
compared to SLAI, but FAMI demonstrated a comparable BIC with SLAI. Although both the 
BIC and bone density increased from a 2- to 4-week healing period, bone density showed 
no significant difference among any of the experimental and control groups.
Conclusions: A fibronectin-coated implant surface designed for cell adhesion could in-
crease contact osteogenesis in the early bone healing phase, but an oxysterol-coated im-
plant surface designed for osteoinductivity could not modify early bone healing around 
implants in normal bone physiology.
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INTRODUCTION
Since the dental implant was first introduced, various fixture designs and surface treat-
ments have been developed for enhancement of osseointegration [1,2]. These designs aimed 
to achieve implant treatment with less time required for the healing period and longer-term 
clinical stability. Along the above-mentioned lines, machined-surface dental implants were 
replaced by those with rough surfaces [3]. Notably, sand-blasted, large-grit, acid-etched 
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dental implants not only provide extensively increased contact area 
with adjacent alveolar bone tissue [4], but also enhance cell attach-
ment for de novo bone formation onto the implant surface [5].
Dental implants are supported by underlying bone tissue via di-
rect bone contact (osseointegration); therefore, increasing the bone-
to-implant contact area has been a main research topic in implant 
dentistry [6,7]. In previous studies, newly formed bone could be ob-
served on the dental implant surface even in fatty marrow areas [8], 
in which increased bone density was observed around the dental 
implant compared to the marrow area. These findings can be ex-
plained by contact osteogenesis in Davies’ hypothesis [5,9]. The au-
thor described the mechanism of peri-implant bone healing, in 
which two types of healing are characterized: differential bone for-
mation from recipient bone (distance) and attached cells onto the 
implant surface (contact osteogenesis). Therefore, cellular events, 
including attachment, proliferation, and differentiation on the den-
tal implant surface have been suggested to be the most important 
factors for peri-implant bone healing and, additionally, Davies [5] 
proposed that surface topographies also affect contact osteogenesis. 
Many other studies have proven his hypothesis by demonstrating 
increased bone-implant contact around rough-surfaced implants 
[10,11], such as sandblasted, large-grit, and acid-etched surfaces, 
compared to those with machined surfaces [12,13].
According to the theory of contact osteogenesis, the microtex-
ture of a rough surface could retain fibrin complex on the surface, 
and enable enhanced attachment and migration of undifferentiat-
ed cells, which are the initial steps of bone formation [9,14]. Since 
the clinical success of these rough surface implants [3,15], various 
other approaches have been developed for focusing on enhancing 
cellular events on the modified surfaces, that is, hydrophilic or an-
odized implant surfaces [16-19]. However, the separate effects of 
cellular events, such as cell attachment and differentiation, have 
not yet been elucidated. 
The current development of implant surface technology has tar-
geted the generation of a “biomimetic surface” on dental implants 
[1,20], in which biologic molecules have been applied onto the im-
plant surface to stimulate osteogenesis and mimic each develop-
mental step in the healing process. Extracellular matrix, peptides, 
and various growth factors are representative biologic molecules. 
Fibronectin is a major extracellular matrix that mediates attach-
ment of cells to other cells or to other surfaces, such as the base-
ment membrane. Recent studies have introduced a fibronectin-
coated dental implant system in the research stage [21,22], and im-
mobilization of fibronectin increased cell attachment [23] and os-
teoblastic protein expression at the in vitro level [24]. Another strat-
egy in creating biomimetic implant surfaces is the use of growth 
factors [25,26] or their natural substitutes, such as oxysterol [27], 
for enhancement of osteogenic cell differentiation. Previous studies 
have demonstrated that oxysterols regulate differentiation of stem 
cells into osteogenic cells via the hedgehog pathway, and also pre-
vent adipogenic differentiation in vitro [28,29]. Another in vivo 
study also found increased bone healing and augmentation in a 
spinal fusion model in animals [30].
Even though these two types of biomimetic implant surface de-
velopments showed increased cell attachment and differentiation 
in vitro [23,27], there was a lack of enhancement of osseointegra-
tion by using fibronectin or oxysterol in clinically-mimicking an in 
vivo animal model. Therefore, the present study aimed to evaluate 
the effects of fibronectin and oxysterol immobilized on machined-
surface dental implants for the enhancement of cell attachment 
and osteogenic differentiation, on peri-implant bone healing in the 
early healing phase using an experimental model in dogs.
MATERIALS AND METHODS
Animals
Five male mongrel dogs, aged 18–24 months and weighing ap-
proximately 30 kg, were used. All of the dogs had intact dentition 
and a healthy periodontium. Animal selection, management, and 
preparation, as well as the surgical protocol, followed the routine 
procedure approved by the Animal Care and Use Committee, Yon-
sei Medical Center, Seoul, Korea (2011-0072-1).
Implant preparation
Machined-surface implant (MI)
Cylindrical, threaded implants of commercially pure titanium (Ø3.4 
mm, 10-mm length) with a machined surface were provided from 
the Research Institute of Dentium, Seoul, Korea.
Apatite-coated MI (AMI)
The MI was treated by calcium phosphate (CaP) nano-coating at 
a thickness of 500 nm, using ion beam-assisted deposition, as de-
scribed previously [22]. For apatite formation on CaP-coated sur-
faces, samples were immersed into the solution, including Dulbec-
co’s phosphate-buffered saline (DPBS, Gibco-BRL, a division of Life 
Technology, Grnad Island, NY, USA) and reagent grade CaCl2 (100 
mg/L). Apatite-coated samples were then rinsed with distilled wa-
ter twice and dried at ambient temperature.
Fibronectin-loaded and AMI (FAMI)
FAMI samples were fabricated using the same method as for 
AMI, except that DPBS solution containing fibronectin was used in-
stead of normal DPBS. 
Oxysterol-loaded and AMI (OAMI)
CaP-coated, MIs were immersed in DPBS solution containing 
oxysterol for 2 days, and washed three times with distilled water 
and dried. The samples were immersed again in DPBS solution with-
out oxysterol for one more day for additional apatite coating on 
the oxysterol/apatite coated surface, and then washed and dried.
Sand-blasted, large-grit, acid-etched surface implant (SLAI) 
Commercially available dental implants (Implantium, Dentium 
Co., Seoul, Korea), which were treated by large grit sand-blasting 
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and further etching, were used as a positive control group.
Study design and surgical protocol
Ten experimental groups were allocated according to the type of 
implant surface (MI, AMI, FAMI, OAMI, and SLAI) and observational 
period (2 and 4 weeks). Five types of implants were installed in a 
randomly selected unilateral edentulous ridge, and the same types 
of implants were installed on the contralateral side at 2 weeks after 
the first surgery. The order of installation sites was rotated in five 
animals for even distribution of the experimental site. After allow-
ing differential healing periods (2 and 4 weeks) following implant 
installation surgery, the animals were sacrificed for histological 
analysis.
Twelve weeks before implant installation surgery, all premolars 
and first molars were extracted at both mandibles under general 
anesthesia and sterile conditions in an operating room using 0.05 
mg/kg atropine (subcutaneous injection), 2 mg/kg xylazine (Rom-
pun, Bayer Korea, Seoul, Korea), and 10 mg/kg ketamine hydrochlo-
ride (Ketalar, Yuhan Co., Seoul, Korea) intravenously. The dogs were 
placed on a heating pad, intubated, administered 2% enflurane, 
and monitored with an electrocardiogram. After disinfecting the 
surgical sites, 2% lidocaine HCl with epinephrine 1:100,000 (Kwang-
myung Pharm, Seoul, Korea) was administered by infiltration at the 
surgical sites. Implant installation operations were also performed 
under the same conditions as the tooth extraction procedure. A 
midcrestal incision was made, and mucoperiosteal flaps were care-
fully reflected on the buccal and lingual aspects. The edentulous 
ridge was carefully flattened with a surgical bur under sterile saline 
irrigation in order to obtain a widened ridge to accommodate a 
standardized ridge shape. Five prefabricated implants were installed 
in rotational order from anterior to posterior sites in individual ani-
mals with an even distribution of installed sites in each group, and 
the same order of installed implants was applied at both sides of 
the edentulous ridge in the same animal. Implant site preparation 
was performed by sequential drilling, and the flaps were sutured 
after implant installation using 5-0 resorbable suture materials (Vic-
ryl 5/0, Polyglactin 910, Ethicon, a division of Johnson & Johnson, 
Somerville, NJ, USA). The sutures were removed after 7–10 days, 
and a soft diet was provided throughout the study period.
Histologic preparation
The animals were sacrificed with an anesthesia drug overdose, 
and block sections, including segments of implants, were preserved 
and fixed in 10% neutral-buffered formalin. The specimens were 
dehydrated in ethanol, embedded in methacrylate, and sectioned 
in the mesio-distal plane using a diamond saw (Exakt, Apparate-
bau, Norderstedt, Germany). From each implant site, a central sec-
tion was taken to a final thickness of about 30 μm, and the sec-
tions were stained with hematoxylin and eosin.
Histologic and histometric analysis
Histologic and histometric analyses were performed using incan-
descent and polarized light microscopy (Olympus Research System 
Microscope BX51, Olympus Co., Tokyo, Japan) and a PC-based image 
analysis system (Image-Pro Plus, Media Cybernetic, Silver Spring, 
MD, USA). The bone-to-implant contact proportion (BIC) and bone 
density in the space between two threads were measured along the 
whole length of the implants. The bone density was defined as the 
proportion of newly formed bone in the interthread space. At four 
sites among a total of 50 experimental samples, the implant apex 
area intruding into the mandibular canal was excluded in the histo-
metric analysis, and this area did not exceed 2 mm in length in any 
of the four cases (Fig. 1).
Statistical analysis
Statistical analysis was performed using a commercially avail-
able software program IBM SPSS Statistics ver. 20.0 (IBM Co., Ar-
monk, NY, USA). The linear mixed model was used to estimate the 
contributions of two fixed effects (types of surface treatment and 
observational periods) and a random effect (animal subject) to the 
histometric results of the bone-to-implant interface (BIC and bone 
density). Because there was no interaction between the two fac-
tors (P=0.457 for BIC and P=0.359 for bone density), the experi-
mental groups in the same observational period and the same ex-
perimental groups with different observational periods were com-
pared separately using repeated measures analysis of variance and 
a paired t-test, respectively. The level of significance was set at 5%.
RESULTS
Clinical observation
After the use of sequential drills and a countersink drill, all im-
plants were installed at the final torque of 30–50 N∙m on the day 
of implant installation. All sites underwent uneventful healing dur-
ing the whole experimental period, with limited signs of inflamma-
tion and cover-screw exposure. 
Histologic observation
All specimens, except one implant, showed direct bone contact 
with the implant surface (osseointegration) along the whole length 
of the dental implants. One site in the FAMI group showed fibrous 
encapsulation without any bone contact, and this was excluded in 
histometric analyses. Four among the 50 installed implants pro-
truded into the mandibular canal, and no bone formation occurred 
in the protruding area; however, those lengths did not exceed 2 or 
3 threads of the dental implant from the apex.
At the observational period of 2 weeks, about half of the dental 
implant surfaces directly contacted the newly formed bone. Nota-
bly, in specimens from the FAMI and SLAI groups, newly formed 
bone continuously lined the entire surface, while the MIs with and 
without the other coating methods showed a partial or limited lin-
ing of osseointegration (Figs. 1 and 2). Two types of bone trabecula 
could be observed: One type appeared to sprout from the recipient 
bone tissue (black asterisks in Fig. 2), and the other type was wo-
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ven bone lining newly formed on the implant surface without any 
relationship with the recipient bone tissue (yellow asterisks in Fig. 
2C and E). Most of FAMIs and SLAIs showed the latter type of bone 
tissue, suggesting contact osteogenesis in the healing processes of 
osseointegration.
In the specimens from all groups at 4 weeks, newly formed bone 
tissue increased around the surface and in the space between the 
implant threads (Figs. 3 and 4). The proportion of newly formed 
woven bone around the implant was reduced at 4 weeks compared 
to 2 weeks.
Figure 1. Representative photomicrographs of all experimental and control groups at 2 weeks after implant installation. All specimens showed initial bony 
healing phases around dental implants, in which woven bone could be found at the prepared or resorbed area of the recipient alveolar bone. An increased 
number of thin bony trabeculae in newly formed bone was demonstrated in the area adjacent to the implant, including the spaces between threads. There were 
no significant differences between groups visible at this low magnification. Some implants (4 of a total of 50 experimentally installed implants) protruded into 
the mandibular canal, due to a lack of height of the residual alveolar ridge (C; arrows indicate superior border of the mandibular canal). These pieces of implant 
in the canal area were excluded from the histometric analyses. (A) Machined-surface implant (MI), (B) apatite-coated MI (AMI), (C) fibronectin-loaded and AMI, 
(D) oxysterol-loaded and AMI, and (E) sand-blasted, large-grit, and acid-etched surface implant. The scale bars in all panels were 1 mm.
A B C D E
Figure 2. High magnification views of representative experimental and control samples at 2 weeks. All photographs were taken from the middle of the im-
plants, showing the space between the implant threads. In these spaces of machined-surface implant (MI) (A), apatite-coated MI (AMI) (B), and oxysterol-load-
ed and AMI (D), thin bony trabecula that appeared sprouting from the recipient bone (black asterisks), approached the implant surfaces, whereas fibronectin-
loaded and AMI (C) and sand-blasted, large-grit, and acid-etched surface implant (E) showed rims of newly formed bone contacting the implant surface (yellow 
asterisks) in most of the surface area, indicating contact osteogenesis. The scale bars in all panels represent 100 μm.
A B C
D E
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Histometric analysis
The results of histometric analyses (mean, standard deviation, 
and 95% confidence interval for the mean) were presented in Ta-
bles 1 and 2 and Fig. 5. Statistical analyses using a linear mixed 
model revealed that the BICs were significantly different between 
groups, according to the observational period (P<0.01) and type of 
surface treatment (P<0.01). At the 2-week observational period, 
the BIC averaged 54.08% ±9.50%, 59.94% ±5.49%, 68.54% ± 
11.42%, 58.65%±8.84%, and 77.14%±7.38% for the MI, AMI, 
FAMI, OAMI, and SLAI groups, respectively. The SLAI group, as a 
positive control, showed the highest BIC among all groups, and 
there were significant differences from the MI (P <0.01), AMI 
Figure 3. Representative photomicrographs of all experimental and control groups at 4 weeks after implant installation. The woven bone area had decreased in all 
of the specimens at the 4-week observational period. Most of the spaces between threads were filled with lamellated bone rather than woven bone, and in-
creased, direct contact of bone to dental implants could be found along the whole length of the dental implants. There were still no significant differences in 
bone healing visible at the bone-to-implant interface in low magnification views. (A) Machined-surface implant (MI), (B) apatite-coated MI (AMI), (C) fibronectin-
loaded and AMI, (D) oxysterol-loaded and AMI, and (E) sand-blasted, large-grit, and acid-etched surface implant. The scale bars in all panels represented 1 mm.
A B C D E
Figure 4. High magnification views of representative experimental and control samples at 4 weeks. All of the spaces between threads were filled with newly 
formed bone with high density. (A, B, D) Newly formed bone appeared in these spaces, approaching the implant surface from the recipient bone. The newly 
formed bone was partially in contact with the surface. (C, E) Thickened rims of newly formed bone on the surface could be found at most of the installed implant 
surface area, and connected with recipient bone tissues or regenerated bone sprouting from the lamellated bone around the dental implants. (A) Machined-sur-
face implant (MI), (B) apatite-coated MI (AMI), (C) fibronectin-loaded and AMI, (D) oxysterol-loaded and AMI, and (E) sand-blasted, large-grit, and acid-etched 
surface implant. Scale bars in all panels were 100 μm.
A B C
D E
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(P=0.04), and OAMI (P=0.03) groups. Although there was no sig-
nificant difference in BIC between the FAMI and SLAI groups, the 
FAMI group had a wider confidence interval for the mean BIC than 
the SLAI group; a similar maximum level of confidence interval was 
found in FAMI (86.70%) and SLAI (86.30%), but the corresponding 
values for the minimum levels of intervals were 50.37% and 
67.98%, respectively. The other experimental groups (MI, AMI, and 
OAMI) showed a significantly increased BIC at 4 weeks compared to 
the same experimental group at 2 weeks (P=0.03, P=0.04, and 
P=0.02, respectively). In addition, there were no significant differ-
ences in BIC between any of the groups at the 4-week observation-
al period, when the BIC averaged 70.53%±7.77%, 71.10%±11.75%, 
73.95%±9.74%, 74.94%±5.55%, and 84.34%±4.06% for the MI, 
AMI, FAMI, OAMI, and SLAI groups, respectively.
Significantly increased bone density was found from the 2-week 
to 4-week observational periods in the linear mixed model (P<0.01), 
but no effects were found according to the type of surface treatment 
(P=0.134). Bone density at the 2-week observational period averaged 
29.84%±11.80%, 33.99%±4.57%, 33.78%±9.34%, 34.23%±8.99%, 
and 42.74%±3.42% for the MI, AMI, FAMI, OAMI, and SLAI groups, 
respectively. The corresponding values for bone density at 4 weeks 
were 46.92%±9.58%, 50.82%±11.89%, 42.62%±3.96%, 51.91%± 
2.86%, and 50.18%±7.75%, respectively; there were significant dif-
ferences from 2 weeks to 4 weeks in MI (P=0.02), AMI (P=0.03), and 
OAMI (P=0.01). 
DISCUSSION
This study was based on our two previous studies that demon-
strated an increase in cell adhesion on fibronectin and patite-coat-
ed titanium surfaces [23] and enhancement of osteoblastic differ-
entiation by oxysterol and apatite-coated titanium surfaces [27]. 
Since the development of dental implants using titanium, various 
surface treatments have been studied to make a bioactive titanium 
surface through the concept of mimicking cellular events in bone 
formation and remodeling processes [1,20]. The two above-men-
Table 1. Results of histometric analyses in bone-to-implant contact proportion.
Group
2 Weeks 4 Weeks
Mean±SD 95% CI Mean±SD 95% CI
MI 54.08±9.50a) 42.29–65.88 70.53±7.77d) 60.88–80.17
AMI 59.94±5.49b) 52.72–66.36 71.10±11.75e) 56.51–85.69
FAMI 68.54±11.42 50.37–86.70 73.95±9.74 61.86–86.04
OAMI 58.65±8.84c) 47.66–69.63 74.94±5.55f) 68.04–81.83
SLAI 77.14±7.38 67.98–86.30 84.34±4.06 79.30–89.38
SD: standard deviation, CI: confidence interval, MI: machined-surface implant, AMI: apatite- 
coated MI, FAMI: fibronectin-loaded and AMI, OAMI: oxysterol-loaded and AMI, SLAI: 
sand-blasted, large-grit, and acid-etched surface implant.
a)Significantly different between measurements in MI and SLAI groups (P=0.004). 
b)Significantly different between measurements in AMI and SLAI groups (P=0.031). 
c)Significantly different between measurements in OAMI and SLAI groups (P=0.022). 
d,e,f)Significantly different between at 2- and 4-week period measurements in the same 
group (d)P=0.019, e)P=0.042, f)P=0.015).
Table 2. Results of histometric analyses in bone density.
Group
2 Weeks 4 Weeks
Mean±SD 95% CI Mean±SD 95% CI
MI 29.84±11.80 15.18–44.50 46.92±9.58a) 35.02–58.82
AMI 33.99±4.57 28.31–39.67 50.82±11.89b) 36.06–65.58
FAMI 33.78±9.34 18.91–48.65 42.62±3.96 37.71–47.53
OAMI 34.23±8.99 23.07–45.39 51.91±2.86c) 48.36–55.46
SLAI 42.74±3.42 38.49–46.98 50.18±7.75 40.55–59.80
SD: standard deviation, CI: confidence interval, MI: machined-surface implant, AMI: apatite- 
coated MI, FAMI: fibronectin-loaded and AMI, OAMI: oxysterol-loaded and AMI, SLAI: 
sand-blasted, large-grit, and acid-etched surface implant.
a,b,c)Significantly different between at 2- and 4-week period measurements in the same 
group (a)P=0.014, b)P=0.017, c)P=0.010).
Figure 5. Results of histometric analyses of the proportion of bone-to-implant contact (%) and bone density (%). Asterisks (*) indicate significant differences as 
shown by statistical analyses. MI: machined-surface implant, AMI: apatite-coated MI, FAMI: fibronectin-loaded and AMI, OAMI: oxysterol-loaded and AMI, SLAI: 
sand-blasted, large-grit, and acid-etched surface implant.
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tioned types of implant surfaces were also intended to transform 
the surface from “biotolerant” to “bioactive” titanium: The fibro-
nectin and apatite coating was intended to promote cellular adhe-
sion onto the surface as a first step in the healing process [23], and 
the oxysterol or apatite coating was intended to promote differen-
tiation of the adhered cells [27]. However, most dental clinicians 
still prefer rough surface implants without any biomimetic surface 
modification, even though various types of biomimetic surface 
implants have been commercially available. A systematic review of 
the Cochrane Collaboration reported that there was no clinical evi-
dence of superiority in any particular type of dental implant [31]. 
The present study aimed to determine whether biomimetic im-
plant surfaces that showed greater cell attachment and differenti-
ation at in vitro level [23,27] could enhance the histologic parame-
ters of the bone-to-implant interface in experiments in vivo mim-
icking clinical situations. In the present experimental model of nor-
mal bone without any defects, two types of bone healing patterns 
were observed around the dental implant surface: (1) a thin rim of 
woven bone deposited onto the implant surface (yellow asterisks in 
Fig. 2); and (2) bony trabecula sprouting from recipient bone tissue 
and contacting the implant surface (black asterisks in Fig. 2). These 
correspond to distance osteogenesis and contact osteogenesis in 
Davies’ hypothesis [5], respectively. In a previous study, Davies de-
scribed contact osteogenesis, in which de novo bone formation oc-
curred on the implant surface; this pattern of healing was also 
demonstrated in the present results [5,9]. At the 2-week observa-
tional period, mineralized tissue could be seen on the implant sur-
face contacting connective tissue fibers. Furthermore, the thickness 
and degrees of mineralization were varied, which indicated the 
bone formation process originated from the implant surface rather 
than the recipient bone tissue. 
The sites receiving FAMI showed histologic evidence of contact 
osteogenesis along a larger area of the implant surface compared 
to the other experimental groups at 2 weeks of healing. The first 
step in contact osteogenesis would be cell adhesion onto the im-
plant surface, followed by further cellular events, including prolif-
eration and differentiation [14]. Fibronectin binds to cell adhesion 
molecules (integrin) on the cell surface, and increases/stabilizes 
cell-cell/cell-stratum adhesion [32,33]; therefore, these in vivo re-
sults might be caused by the function of fibronectin, like in vitro 
results. This healing pattern could also be demonstrated in sites re-
ceiving SLAI as a positive control group. Numerous previous studies 
have already found increased bone-to-implant contact in SLA-sur-
faced implants compared to MIs, which resulted from increased 
surface energy by microroughness of the surface [13,34,35]. In the 
histometric results, the SLAI group showed a higher BIC compared 
to the other three experimental groups (MI, AMI, and OAMI), and 
there was no significant difference between the FAMI and SLAI 
groups. However, the FAMI group also did not show any differenc-
es from the other groups, unlike the SLAI group. While the SLAI 
group showed a narrow range of histometric results, sites receiving 
FAMI showed a relatively wide range of results with regard to the 
BIC proportion; 95% confidence intervals for the mean were 67.98–
86.30 in the SLAI group and 50.37–86.70 in the FAMI group. Rough 
surface implants can provide increased contact surface and me-
chanical interlocking with the recipient bone tissue [11,36], and 
these might increase the stability of SLAI during the early healing 
period. Increasing the stability of implants could also stabilize the in 
vivo healing process, which can be influenced by not only cellular 
events, but also the various environments of the recipient site (bone 
quality, biologic responses by cytokines, and immune responses). For 
this reason, FAMI might show a less uniform increase in the BIC 
compared to the SLAI, despite enhancement of cell adhesion.
Oxysterol is an oxidized derivative of cholesterol, and its novel 
characteristic of regulating differentiation into osteogenic cells has 
been the subject of increasing research attention. In previous stud-
ies, oxysterol induced in vivo osteogenesis like bone morphogenetic 
protein-2 (BMP-2), or synergistically increased the osteoinductive 
effects of BMP-2 [30,37,38]. Since complications of BMP-2 applica-
tion have emerged in research and clinical fields [39,40], oxysterol 
has received attention as a substitute or regulating factor for BMP-
2. Our previous study also showed an increase in alkaline phospha-
tase with oxysterol surface coating, and simultaneous apatite and 
oxysterol coating could synergistically enhance in vitro osteogenesis 
[27]. In the present study, the authors hypothesized that osteoin-
duction by oxysterol could enhance bone formation by osteoblasts 
adhered to the implant surface, and increase the BIC and bone 
density in the early healing phase. However, oxysterol coating on 
the implant surface failed to enhance the BIC and bone density in 
the space between threads, and these findings are in agreement 
with a previous study [26] that demonstrated that implant surface 
coating with recombinant human BMP-2 did not increase the BIC 
or bone density in a nondefect, normal bone area, despite success-
ful vertical augmentation in the supra-alveolar defect area without 
any graft materials [25,26]. Osteoinductive molecules might not 
accelerate or enhance bone healing at the bone-to-implant inter-
face in normal bone, even though they can increase bone forma-
tion in the area with unfavorable defects. However, to confirm 
these hypotheses, further studies should be performed in various 
defect models. 
This study aimed to determine the effects of enhancement of cell 
adhesion onto the implant surface and osteogenic differentiation 
by surface coating techniques on bone healing processes, especially 
at the bone-to-implant interface, in the early healing phase. Two 
types of implants focusing on cell adhesion increased the BIC at 2 
weeks after implant installation: sand-blasted/acid-etched and fi-
bronectin-coated surface implants. However, surface coating with 
osteoinductive molecules did not modify the BIC or bone density 
around any of the implant surfaces. Cell adhesion onto the implant 
surface may enhance contact osteogenesis around the implant in 
the early healing phase, when the implant is installed in normal 
bone without any defect.
Jung-Seok Lee et al.
dx.doi.org/10.5051/jpis.2014.44.5.242
www.jpis.org 249
CONFLICT OF INTEREST
No potential conflict of interest relevant to this article was re-
ported.
ACKNOWLEDGEMENTS 
This research was supported by the Basic Science Research Pro-
gram through the National Research Foundation of Korea (NRF) 
funded by the Ministry of Education (NRF-2013R1A1A2060464). 
ORCID
Jung-Seok Lee http://orcid.org/0000-0003-1276-5978
Jin-Hyuk Yang http://orcid.org/0000-0002-8238-1374
Ji-Youn Hong http://orcid.org/0000-0003-1040-7077
Ui-Won Jung http://orcid.org/0000-0001-6371-4172
Hyeong-Cheol Yang http://orcid.org/0000-0001-9420-7894
In-Seop Lee http://orcid.org/0000-0002-0407-0431
Seong-Ho Choi http://orcid.org/0000-0001-6704-6124
REFERENCES
1. Choi AH, Ben-Nissan B, Matinlinna JP, Conway RC. Current per-
spectives: calcium phosphate nanocoatings and nanocomposite 
coatings in dentistry. J Dent Res 2013;92:853-9.
2. Sykaras N, Iacopino AM, Marker VA, Triplett RG, Woody RD. Im-
plant materials, designs, and surface topographies: their effect 
on osseointegration: a literature review. Int J Oral Maxillofac Im-
plants 2000;15:675-90.
3. Scacchi M, Merz BR, Schar AR. The development of the ITI DENTAL 
IMPLANT SYSTEM. Part 2: 1998-2000: Steps into the next millen-
nium. Clin Oral Implants Res 2000;11 Suppl 1:22-32.
4. Cochran DL, Schenk RK, Lussi A, Higginbottom FL, Buser D. Bone 
response to unloaded and loaded titanium implants with a sand-
blasted and acid-etched surface: a histometric study in the ca-
nine mandible. J Biomed Mater Res 1998;40:1-11.
5. Davies JE. Mechanisms of endosseous integration. Int J Prostho-
dont 1998;11:391-401.
6. Weber HP, Fiorellini JP. The biology and morphology of the im-
plant-tissue interface. Alpha Omegan 1992;85:61-4.
7. Albrektsson T, Branemark PI, Hansson HA, Lindstrom J. Osseointe-
grated titanium implants. Requirements for ensuring a long-last-
ing, direct bone-to-implant anchorage in man. Acta Orthop Scand 
1981;52:155-70.
8. Rahal MD, Branemark PI, Osmond DG. Response of bone marrow 
to titanium implants: osseointegration and the establishment of 
a bone marrow-titanium interface in mice. Int J Oral Maxillofac 
Implants 1993;8:573-9.
9. Davies JE. Understanding peri-implant endosseous healing. J Dent 
Educ 2003;67:932-49.
10. Ericsson I, Johansson CB, Bystedt H, Norton MR. A histomorpho-
metric evaluation of bone-to-implant contact on machine-pre-
pared and roughened titanium dental implants: a pilot study in 
the dog. Clin Oral Implants Res 1994;5:202-6.
11. Cooper LF. A role for surface topography in creating and main-
taining bone at titanium endosseous implants. J Prosthet Dent 
2000;84:522-34.
12. Buser D, Nydegger T, Oxland T, Cochran DL, Schenk RK, Hirt HP, et 
al. Interface shear strength of titanium implants with a sand-
blasted and acid-etched surface: a biomechanical study in the 
maxilla of miniature pigs. J Biomed Mater Res 1999;45:75-83.
13. Buser D, Schenk RK, Steinemann S, Fiorellini JP, Fox CH, Stich H. 
Influence of surface characteristics on bone integration of tita-
nium implants: a histomorphometric study in miniature pigs. J 
Biomed Mater Res 1991;25:889-902.
14. Park JY, Gemmell CH, Davies JE. Platelet interactions with titani-
um: modulation of platelet activity by surface topography. Bio-
materials 2001;22:2671-82.
15. Cochran DL, Buser D, ten Bruggenkate CM, Weingart D, Taylor 
TM, Bernard JP, et al. The use of reduced healing times on ITI im-
plants with a sandblasted and acid-etched (SLA) surface: early 
results from clinical trials on ITI SLA implants. Clin Oral Implants 
Res 2002;13:144-53.
16. Lai HC, Zhuang LF, Liu X, Wieland M, Zhang ZY, Zhang ZY. The in-
fluence of surface energy on early adherent events of osteoblast 
on titanium substrates. J Biomed Mater Res A 2010;93:289-96.
17. Wall I, Donos N, Carlqvist K, Jones F, Brett P. Modified titanium 
surfaces promote accelerated osteogenic differentiation of mes-
enchymal stromal cells in vitro. Bone 2009;45:17-26.
18. Qu Z, Rausch-Fan X, Wieland M, Matejka M, Schedle A. The initial 
attachment and subsequent behavior regulation of osteoblasts by 
dental implant surface modification. J Biomed Mater Res A 2007; 
82:658-68.
19. Li Y, Lee IS, Cui FZ, Choi SH. The biocompatibility of nanostruc-
tured calcium phosphate coated on micro-arc oxidized titanium. 
Biomaterials 2008;29:2025-32.
20. Le Guehennec L, Soueidan A, Layrolle P, Amouriq Y. Surface treat-
ments of titanium dental implants for rapid osseointegration. 
Dent Mater 2007;23:844-54.
21. Kim S, Myung WC, Lee JS, Cha JK, Jung UW, Yang HC, et al. The 
effect of fibronectin-coated implant on canine osseointegration. 
J Periodontal Implant Sci 2011;41:242-7.
22. Hilbig H, Kirsten M, Rupietta R, Graf HL, Thalhammer S, Strasser S, 
et al. Implant surface coatings with bone sialoprotein, collagen, 
and fibronectin and their effects on cells derived from human 
maxillar bone. Eur J Med Res 2007;12:6-12.
23. Chen C, Lee IS, Zhang SM, Yang HC. Biomimetic apatite forma-
tion on calcium phosphate-coated titanium in Dulbecco's phos-
phate-buffered saline solution containing CaCl(2) with and with-
out fibronectin. Acta Biomater 2010;6:2274-81.
24. Gorbahn M, Klein MO, Lehnert M, Ziebart T, Brullmann D, Koper I, 
et al. Promotion of osteogenic cell response using quasicovalent 
immobilized fibronectin on titanium surfaces: introduction of a 
Effects of cell adhesion/osteoinduction on osseointegration
dx.doi.org/10.5051/jpis.2014.44.5.242
www.jpis.org250
novel biomimetic layer system. J Oral Maxillofac Surg 2012;70: 
1827-34.
25. Leknes KN, Yang J, Qahash M, Polimeni G, Susin C, Wikesjo UM. 
Alveolar ridge augmentation using implants coated with recom-
binant human bone morphogenetic protein-2: radiographic ob-
servations. Clin Oral Implants Res 2008;19:1027-33.
26. Wikesjo UM, Qahash M, Polimeni G, Susin C, Shanaman RH, Rohrer 
MD, et al. Alveolar ridge augmentation using implants coated 
with recombinant human bone morphogenetic protein-2: histo-
logic observations. J Clin Periodontol 2008;35:1001-10.
27. Son KM, Park HC, Kim NR, Lee IS, Yang HC. Enhancement of the 
ALP activity of C3H10T1/2 cells by the combination of an oxys-
terol and apatite. Biomed Mater 2010;5:044107.
28. Stappenbeck F, Xiao W, Epperson M, Riley M, Priest A, Huang D, et 
al. Novel oxysterols activate the Hedgehog pathway and induce 
osteogenesis. Bioorg Med Chem Lett 2012;22:5893-7.
29. Aghaloo TL, Amantea CM, Cowan CM, Richardson JA, Wu BM, 
Parhami F, et al. Oxysterols enhance osteoblast differentiation in 
vitro and bone healing in vivo. J Orthop Res 2007;25:1488-97.
30. Johnson JS, Meliton V, Kim WK, Lee KB, Wang JC, Nguyen K, et al. 
Novel oxysterols have pro-osteogenic and anti-adipogenic effects 
in vitro and induce spinal fusion in vivo. J Cell Biochem 2011;112: 
1673-84.
31. Esposito M, Murray-Curtis L, Grusovin MG, Coulthard P, Worthing-
ton HV. Interventions for replacing missing teeth: different types 
of dental implants. Cochrane Database Syst Rev 2007;(4):C 
D003815.
32. Hynes RO. Integrins: versatility, modulation, and signaling in cell 
adhesion. Cell 1992;69:11-25.
33. Parsons JT, Horwitz AR, Schwartz MA. Cell adhesion: integrating 
cytoskeletal dynamics and cellular tension. Nat Rev Mol Cell Biol 
2010;11:633-43.
34. Abrahamsson I, Berglundh T, Linder E, Lang NP, Lindhe J. Early 
bone formation adjacent to rough and turned endosseous im-
plant surfaces: an experimental study in the dog. Clin Oral Im-
plants Res 2004;15:381-92.
35. Piattelli A, Manzon L, Scarano A, Paolantonio M, Piattelli M. His-
tologic and histomorphometric analysis of the bone response to 
machined and sandblasted titanium implants: an experimental 
study in rabbits. Int J Oral Maxillofac Implants 1998;13:805-10.
36. Li D, Ferguson SJ, Beutler T, Cochran DL, Sittig C, Hirt HP, et al. 
Biomechanical comparison of the sandblasted and acid-etched 
and the machined and acid-etched titanium surface for dental 
implants. J Biomed Mater Res 2002;60:325-32.
37. Amantea CM, Kim WK, Meliton V, Tetradis S, Parhami F. Oxyster-
ol-induced osteogenic differentiation of marrow stromal cells is 
regulated by Dkk-1 inhibitable and PI3-kinase mediated signal-
ing. J Cell Biochem 2008;105:424-36.
38. Kha HT, Basseri B, Shouhed D, Richardson J, Tetradis S, Hahn TJ, 
et al. Oxysterols regulate differentiation of mesenchymal stem 
cells: pro-bone and anti-fat. J Bone Miner Res 2004;19:830-40.
39. Choi Y, Lee JS, Kim YJ, Kim MS, Choi SH, Cho KS, et al. Recombi-
nant human bone morphogenetic protein-2 stimulates the os-
teogenic potential of the Schneiderian membrane: a histometric 
analysis in rabbits. Tissue Eng Part A 2013;19:1994-2004.
40. Zara JN, Siu RK, Zhang X, Shen J, Ngo R, Lee M, et al. High doses of 
bone morphogenetic protein 2 induce structurally abnormal bone 
and inflammation in vivo. Tissue Eng Part A 2011;17:1389-99.
